
Chemical and Pharmaceutical Bulletin p. 1455 - 1463 (1999)
Update date:2022-08-03
Topics:
Ikeda, Hisafumi
Fuji, Kaoru
Tanaka, Kiyoshi
Iso, Yasuyoshi
Yoneda, Fumio
Aiming at the creation of functionalized antisense DNA oligomers possessing site-selective DNA cleaving activity, viologen and a related compound, diazapyrenium dication (DAP2+), were selected and introduced into oligodeoxyribonucleotides as a functionalized molecule. The conjugation of these functionalized molecules with DNA proceeded smoothly by using standard H-phosphonate chemistry. A part of the DAP2+-tethered DNA oligomers was synthesized by a combination of solid support method and liquid phase technique. Viologen-tethered DNA oligomers showed no significant activity toward DNA cleavage in spite of their characteristic ESR spectra. On the other hand, it was observed that the DAP2+-tethered DNA oligomers formed more stable duplexes with their complementary strands than the corresponding wild type, and these molecules effectively cleaved the complementary strands at the specific site of 2 - 3 bases away from the modified phosphoramidate linkage. The effect of position and length of the linker arm on the selectivity in the cleavage reaction was also investigated, and it was found that introduction at the 3'- or 5'-end phosphate site is more favorable, probably due to duplex stabilization.
View MoreHangzhou jls Flame Retardants Chemical Co.,Ltd
Contact:+86-571-87250387/87250386
Address:MOGANSHAN RODA 1418# SHANGCHENG INDUSTRIAL PARK
Wuhan Silworld Chemical Co.,Ltd
website:http://www.silworldchemical.com
Contact:+86-27-85613400
Address:No.198 jiangjun Road, Wuhan,China 430033
Contact:+1 (647) 918 5848
Address:2343 BRIMLEY RD., Suite 250
Nanyang Tianhua pharmaceutical Co.,Ltd.
Contact:+8618639816203
Address:Longsheng Industrial Park
JIN TAN CHENG'EN CHEMICAL CO.,LTD.
Contact:86-519-82116250
Address:NO.102,village Dongfang,conomic development zone
Doi:10.1016/S0040-4020(01)81283-7
(1993)Doi:10.1248/cpb.26.2132
(1978)Doi:10.1016/S0022-328X(00)83982-0
(1980)Doi:10.1007/s10593-009-0291-x
(2009)Doi:10.1002/ejic.200300252
(2003)Doi:10.1039/c4cc06427e
(2014)